Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Revenue

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,017 Cr₹853 Cr₹71 Cr₹617 Cr₹5,123 Cr

What is the latest Revenue of CONCORD BIOTECH ?

The latest Revenue ratio of CONCORD BIOTECH is ₹1,017 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,017 Cr
Mar2024₹853 Cr
Mar2023₹71 Cr
Mar2022₹617 Cr
Mar2021₹5,123 Cr

How is Revenue of CONCORD BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹1,017 Cr
19.20
Mar2024 ₹853 Cr
1,096.71
Mar2023 ₹71 Cr
-88.44
Mar2022 ₹617 Cr
-87.96
Mar2021 ₹5,123 Cr -

Compare Revenue of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹10,813.5 Cr -8.5% -7.7% -33.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-8.5%

-7.7%

-33.9%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses